🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Australia / NCT06110962
Recruiting Observational

Detecting Heart Rate, Respiration, and Sleep With the Sleeptracker-AI Under-mattress Monitor

NCT06110962 · tracked via the Priya Life Science Australia tracker
Phase
Observational
Started
2024-07-10
Last updated
2025-03-28

Condition(s) studied

OSA

Investigational drug(s) / intervention(s)

Sleeptracker-AI

Sleeptracker-AI: The Sleeptracker-AI Monitor (Fullpower Technologies, California, USA) is a commercially available, unobtrusive, and non-wearable home sleep monitoring device. It is either pre-installed in a mattress or can be purchased separately by consumers where it is placed under the mattress. The device uses piezo-electric sensors that register the forces exerted through the mattress by features such as the subject's motion, respiration, heartbeats, and snoring vibrations.

Study summary

The objective of this study is to simultaneously acquire sleep and breathing data using the under-mattress Sleeptracker (The Sleeptracker-AI Monitor (Fullpower Technologies, California, USA) during routine PSGs in patients who attend the Woolcock Institute for undergoing investigation for possible obstructive sleep apnoea (OSA).

Eligibility

Sex
ALL
Min age
20 Years
Max age
90 Years
Healthy volunteers
No
Inclusion Criteria: * Adults aged 20-90 years old at time of assessment. * Attending the Woolcock Institute for an overnight sleep study for investigation of sleep apnoea. * Able to give informed consent. * Fluent in English. Exclusion Criteria: * Unable to understand study procedure. * Unable to sign informed consent form.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Woolcock Institute of Medical Research Macquarie Park New South Wales Recruiting

More Woolcock Institute of Medical Research trials in Australia

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06110962 on ClinicalTrials.gov ↗ ← All trials in Australia